These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 28696695)

  • 1. Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators.
    Bohl CE; Wu Z; Chen J; Mohler ML; Yang J; Hwang DJ; Mustafa S; Miller DD; Bell CE; Dalton JT
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5567-70. PubMed ID: 18805694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A screening method for the quantitative determination of selective androgen receptor modulators (SARMs) in capsules by high resolution
    Maccelli A; Borioni A; Aureli F; Gaudiano MC; Manna L; Raimondo M
    Anal Methods; 2024 Apr; 16(14):2135-2146. PubMed ID: 38517236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity-Directed Synthesis with Intermolecular Reactions: Development of a Fragment into a Range of Androgen Receptor Agonists.
    Karageorgis G; Dow M; Aimon A; Warriner S; Nelson A
    Angew Chem Int Ed Engl; 2015 Nov; 54(46):13538-44. PubMed ID: 26358926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing new targeting strategy for androgen receptor variants in castration resistant prostate cancer.
    Wang B; Lo UG; Wu K; Kapur P; Liu X; Huang J; Chen W; Hernandez E; Santoyo J; Ma SH; Pong RC; He D; Cheng YQ; Hsieh JT
    Int J Cancer; 2017 Nov; 141(10):2121-2130. PubMed ID: 28722220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A partially open conformation of an androgen receptor ligand-binding domain with drug-resistance mutations.
    Doamekpor SK; Peng P; Xu R; Ma L; Tong Y; Tong L
    Acta Crystallogr F Struct Biol Commun; 2023 Apr; 79(Pt 4):95-104. PubMed ID: 36995121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural overview and perspectives of the nuclear receptors, a major family as the direct targets for small-molecule drugs.
    Li F; Song C; Zhang Y; Wu D
    Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(1):12-24. PubMed ID: 35130630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational dynamics of androgen receptors bound to agonists and antagonists.
    Gim HJ; Park J; Jung ME; Houk KN
    Sci Rep; 2021 Aug; 11(1):15887. PubMed ID: 34354111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Naïve Bayesian, Chemical Fingerprints and Molecular Docking Classifiers to Model and Predict Androgen Receptor Binding Data for Environmentally- and Health-Sensitive Substances.
    García-Sosa AT; Maran U
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective androgen receptor modulators: the future of androgen therapy?
    Christiansen AR; Lipshultz LI; Hotaling JM; Pastuszak AW
    Transl Androl Urol; 2020 Mar; 9(Suppl 2):S135-S148. PubMed ID: 32257854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications.
    Solomon ZJ; Mirabal JR; Mazur DJ; Kohn TP; Lipshultz LI; Pastuszak AW
    Sex Med Rev; 2019 Jan; 7(1):84-94. PubMed ID: 30503797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of diarylhydantoins as new selective androgen receptor modulators.
    Nique F; Hebbe S; Peixoto C; Annoot D; Lefrançois JM; Duval E; Michoux L; Triballeau N; Lemoullec JM; Mollat P; Thauvin M; Prangé T; Minet D; Clément-Lacroix P; Robin-Jagerschmidt C; Fleury D; Guédin D; Deprez P
    J Med Chem; 2012 Oct; 55(19):8225-35. PubMed ID: 22897611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit.
    Mohler ML; Bohl CE; Jones A; Coss CC; Narayanan R; He Y; Hwang DJ; Dalton JT; Miller DD
    J Med Chem; 2009 Jun; 52(12):3597-617. PubMed ID: 19432422
    [No Abstract]   [Full Text] [Related]  

  • 13. Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity.
    Yarrow JF; McCoy SC; Borst SE
    Steroids; 2010 Jun; 75(6):377-89. PubMed ID: 20138077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Based Approach To Identify 5-[4-Hydroxyphenyl]pyrrole-2-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators.
    Unwalla R; Mousseau JJ; Fadeyi OO; Choi C; Parris K; Hu B; Kenney T; Chippari S; McNally C; Vishwanathan K; Kilbourne E; Thompson C; Nagpal S; Wrobel J; Yudt M; Morris CA; Powell D; Gilbert AM; Chekler ELP
    J Med Chem; 2017 Jul; 60(14):6451-6457. PubMed ID: 28696695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of potent and muscle selective androgen receptor modulators through scaffold modifications.
    Li JJ; Sutton JC; Nirschl A; Zou Y; Wang H; Sun C; Pi Z; Johnson R; Krystek SR; Seethala R; Golla R; Sleph PG; Beehler BC; Grover GJ; Fura A; Vyas VP; Li CY; Gougoutas JZ; Galella MA; Zahler R; Ostrowski J; Hamann LG
    J Med Chem; 2007 Jun; 50(13):3015-25. PubMed ID: 17552509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives.
    Asano M; Hitaka T; Imada T; Yamada M; Morimoto M; Shinohara H; Hara T; Yamaoka M; Santou T; Nakayama M; Imai Y; Habuka N; Yano J; Wilson K; Fujita H; Hasuoka A
    Bioorg Med Chem Lett; 2017 May; 27(9):1897-1901. PubMed ID: 28363748
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.